An Assessment of Statin Safety by Hepatologists Review uri icon

Overview

MeSH Major

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Liver Failure

abstract

  • The purpose of the Liver Expert Panel was to provide advice to the National Lipid Association's (NLA) Safety Task Force in response to specific questions concerning liver-associated risks of statin therapy. The panel was composed of academic hepatologists with clinical and research interests in nonalcoholic fatty liver disease, lipid metabolic disorders, and drug hepatotoxicity.

publication date

  • April 17, 2006

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.amjcard.2005.12.014

PubMed ID

  • 16581333

Additional Document Info

start page

  • 77C

end page

  • 81C

volume

  • 97

number

  • 8 SUPPL. 1